{
    "organizations": [],
    "uuid": "eb807426dabafb1a95cd2ec0daa381d7c44a3ac3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aileron-therapeutics-reports-q4-lo/brief-aileron-therapeutics-reports-q4-loss-of-0-47-per-share-idUSASC09UJL",
    "ord_in_thread": 0,
    "title": "BRIEF-Aileron Therapeutics Reports Q4 Loss Of $0.47 Per Share",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2 (Reuters) - Aileron Therapeutics Inc:\n* AILERON THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.47 * Q4 EARNINGS PER SHARE VIEW $-0.44 â€” THOMSON REUTERS I/B/E/S\n* GAAP LOSS PER SHARE $0.47 * BELIEVES CASH, CASH EQUIVALENTS, INVESTMENTS AS OF DEC 31 TO ENABLE CO TO FUND OPERATING EXPENSES, CAPEX INTO H2 2019 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)\n ",
    "published": "2018-04-03T04:21:00.000+03:00",
    "crawled": "2018-04-03T16:11:08.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "aileron",
        "therapeutic",
        "inc",
        "aileron",
        "therapeutic",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "gaap",
        "loss",
        "per",
        "share",
        "belief",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "dec",
        "enable",
        "co",
        "fund",
        "operating",
        "expense",
        "capex",
        "h2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "bengaluru",
        "newsroom"
    ]
}